| CVX |
CVX Label |
Use Status |
Comment |
| 801 |
AS03 Adjuvant |
SUPPORTED |
Problem: No forecast series references this code |
| 143 |
Adenovirus types 4 and 7 |
SUPPORTED |
Problem: No forecast series references this code |
| 19 |
BCG |
SUPPORTED |
Problem: No forecast series references this code |
| 29 |
CMVIG |
SUPPORTED |
Problem: No forecast series references this code |
| 207 |
COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5 mL dose |
SUPPORTED |
|
| 208 |
COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose |
SUPPORTED |
|
| 28 |
DT (pediatric) |
SUPPORTED |
|
| 195 |
DT, IPV adsorbed |
SUPPORTED |
Problem: No forecast series references this code |
| 170 |
DTAP/IPV/HIB - non-US |
SUPPORTED |
|
| 01 |
DTP |
SUPPORTED |
|
| 22 |
DTP-Hib |
SUPPORTED |
|
| 102 |
DTP-Hib-Hep B |
SUPPORTED |
|
| 198 |
DTP-hepB-Hib Pentavalent Non-US |
SUPPORTED |
|
| 20 |
DTaP |
SUPPORTED |
|
| 106 |
DTaP, 5 pertussis antigens |
SUPPORTED |
|
| 107 |
DTaP, unspecified formulation |
SUPPORTED |
|
| 146 |
DTaP,IPV,Hib,HepB |
SUPPORTED |
|
| 110 |
DTaP-Hep B-IPV |
SUPPORTED |
|
| 50 |
DTaP-Hib |
SUPPORTED |
|
| 120 |
DTaP-Hib-IPV |
SUPPORTED |
|
| 130 |
DTaP-IPV |
SUPPORTED |
|
| 132 |
DTaP-IPV-HIB-HEP B, historical |
SUPPORTED |
|
| 30 |
HBIG |
SUPPORTED |
Problem: No forecast series references this code |
| 61 |
HIV |
SUPPORTED |
Problem: No forecast series references this code |
| 118 |
HPV, bivalent |
SUPPORTED |
|
| 62 |
HPV, quadrivalent |
SUPPORTED |
|
| 137 |
HPV, unspecified formulation |
SUPPORTED |
Problem: No forecast series references this code |
| 165 |
HPV9 |
SUPPORTED |
|
| 52 |
Hep A, adult |
SUPPORTED |
|
| 169 |
Hep A, live attenuated |
SUPPORTED |
Problem: No forecast series references this code |
| 83 |
Hep A, ped/adol, 2 dose |
SUPPORTED |
|
| 84 |
Hep A, ped/adol, 3 dose |
SUPPORTED |
|
| 31 |
Hep A, pediatric, unspecified formulation |
SUPPORTED |
|
| 85 |
Hep A, unspecified formulation |
SUPPORTED |
|
| 104 |
Hep A-Hep B |
SUPPORTED |
|
| 193 |
Hep A-Hep B, pediatric/adolescent |
SUPPORTED |
Problem: No forecast series references this code |
| 08 |
Hep B, adolescent or pediatric |
SUPPORTED |
|
| 42 |
Hep B, adolescent/high risk infant |
SUPPORTED |
|
| 43 |
Hep B, adult |
SUPPORTED |
|
| 44 |
Hep B, dialysis |
SUPPORTED |
|
| 45 |
Hep B, unspecified formulation |
SUPPORTED |
|
| 58 |
Hep C |
SUPPORTED |
Problem: No forecast series references this code |
| 59 |
Hep E |
SUPPORTED |
Problem: No forecast series references this code |
| 189 |
HepB-CpG |
SUPPORTED |
Problem: No forecast series references this code |
| 154 |
Hepatitis A immune globulin |
SUPPORTED |
Problem: No forecast series references this code |
| 47 |
Hib (HbOC) |
SUPPORTED |
|
| 46 |
Hib (PRP-D) |
SUPPORTED |
|
| 49 |
Hib (PRP-OMP) |
SUPPORTED |
|
| 48 |
Hib (PRP-T) |
SUPPORTED |
|
| 17 |
Hib, unspecified formulation |
SUPPORTED |
|
| 51 |
Hib-Hep B |
SUPPORTED |
|
| 86 |
IG |
SUPPORTED |
Problem: No forecast series references this code |
| 14 |
IG, unspecified formulation |
SUPPORTED |
Problem: No forecast series references this code |
| 87 |
IGIV |
SUPPORTED |
Problem: No forecast series references this code |
| 10 |
IPV |
SUPPORTED |
|
| 160 |
Influenza A monovalent (H5N1), ADJUVANTED-2013 |
SUPPORTED |
Problem: No forecast series references this code |
| 151 |
Influenza nasal, unspecified formulation |
SUPPORTED |
|
| 205 |
Influenza vaccine, quadrivalent, adjuvanted |
SUPPORTED |
Problem: No forecast series references this code |
| 194 |
Influenza, Southern Hemisphere |
SUPPORTED |
Problem: No forecast series references this code |
| 135 |
Influenza, high dose seasonal |
SUPPORTED |
|
| 153 |
Influenza, injectable, MDCK, preservative free |
SUPPORTED |
|
| 171 |
Influenza, injectable, MDCK, preservative free, quadrivalent
|
SUPPORTED |
|
| 186 |
Influenza, injectable, MDCK, quadrivalent |
SUPPORTED |
|
| 158 |
Influenza, injectable, quadrivalent |
SUPPORTED |
|
| 150 |
Influenza, injectable, quadrivalent, preservative free |
SUPPORTED |
Problem: No forecast series references this code |
| 161 |
Influenza, injectable,quadrivalent, preservative free,
pediatric
|
SUPPORTED |
|
| 111 |
Influenza, live, intranasal |
SUPPORTED |
|
| 155 |
Influenza, recombinant, injectable, preservative free |
SUPPORTED |
|
| 141 |
Influenza, seasonal, injectable |
SUPPORTED |
|
| 140 |
Influenza, seasonal, injectable, preservative free |
SUPPORTED |
|
| 144 |
Influenza, seasonal, intradermal, preservative free |
SUPPORTED |
|
| 15 |
Influenza, split (incl. purified surface antigen) |
SUPPORTED |
|
| 88 |
Influenza, unspecified formulation |
SUPPORTED |
|
| 16 |
Influenza, whole |
SUPPORTED |
Problem: No forecast series references this code |
| 134 |
Japanese Encephalitis IM |
SUPPORTED |
Problem: No forecast series references this code |
| 129 |
Japanese Encephalitis, unspecified formulation |
SUPPORTED |
Problem: No forecast series references this code |
| 39 |
Japanese encephalitis SC |
SUPPORTED |
Problem: No forecast series references this code |
| 63 |
Junin virus |
SUPPORTED |
Problem: No forecast series references this code |
| 66 |
Lyme disease |
SUPPORTED |
Problem: No forecast series references this code |
| 03 |
MMR |
SUPPORTED |
|
| 94 |
MMRV |
SUPPORTED |
|
| 04 |
Measles and Rubella |
SUPPORTED |
|
| 148 |
Meningococcal C/Y-HIB PRP |
SUPPORTED |
|
| 136 |
Meningococcal MCV4O |
SUPPORTED |
|
| 128 |
Novel Influenza-H1N1-09, all formulations |
SUPPORTED |
|
| 125 |
Novel Influenza-H1N1-09, nasal |
SUPPORTED |
|
| 127 |
Novel influenza-H1N1-09 |
SUPPORTED |
|
| 126 |
Novel influenza-H1N1-09, preservative-free |
SUPPORTED |
|
| 02 |
OPV |
SUPPORTED |
|
| 179 |
OPV ,monovalent, unspecified |
SUPPORTED |
Problem: No forecast series references this code |
| 178 |
OPV bivalent |
SUPPORTED |
Problem: No forecast series references this code |
| 182 |
OPV, Unspecified |
SUPPORTED |
Problem: No forecast series references this code |
| 177 |
PCV10 |
SUPPORTED |
Problem: No forecast series references this code |
| 152 |
Pneumococcal Conjugate, unspecified formulation |
SUPPORTED |
Problem: No forecast series references this code |
| 133 |
Pneumococcal conjugate PCV 13 |
SUPPORTED |
|
| 70 |
Q fever |
SUPPORTED |
Problem: No forecast series references this code |
| 99 |
RESERVED - do not use |
SUPPORTED |
Problem: No forecast series references this code |
| 34 |
RIG |
SUPPORTED |
Problem: No forecast series references this code |
| 71 |
RSV-IGIV |
SUPPORTED |
Problem: No forecast series references this code |
| 93 |
RSV-MAb |
SUPPORTED |
Problem: No forecast series references this code |
| 145 |
RSV-Mab (new) |
SUPPORTED |
Problem: No forecast series references this code |
| 175 |
Rabies - IM Diploid cell culture |
SUPPORTED |
Problem: No forecast series references this code |
| 176 |
Rabies - IM fibroblast culture |
SUPPORTED |
Problem: No forecast series references this code |
| 157 |
Rho(D) -IG IM |
SUPPORTED |
Problem: No forecast series references this code |
| 159 |
Rho(D) Unspecified formulation |
SUPPORTED |
Problem: No forecast series references this code |
| 156 |
Rho(D)-IG |
SUPPORTED |
Problem: No forecast series references this code |
| 73 |
Rift Valley fever |
SUPPORTED |
Problem: No forecast series references this code |
| 213 |
SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED |
SUPPORTED |
|
| 206 |
Smallpox monkeypox vaccine (National Stockpile) |
SUPPORTED |
Problem: No forecast series references this code |
| 76 |
Staphylococcus bacterio lysate |
SUPPORTED |
Problem: No forecast series references this code |
| 13 |
TIG |
SUPPORTED |
Problem: No forecast series references this code |
| 98 |
TST, unspecified formulation |
SUPPORTED |
Problem: No forecast series references this code |
| 95 |
TST-OT tine test |
SUPPORTED |
Problem: No forecast series references this code |
| 96 |
TST-PPD intradermal |
SUPPORTED |
Problem: No forecast series references this code |
| 97 |
TST-PPD tine test |
SUPPORTED |
Problem: No forecast series references this code |
| 138 |
Td (adult) |
SUPPORTED |
Problem: No forecast series references this code |
| 113 |
Td (adult) preservative free |
SUPPORTED |
|
| 09 |
Td (adult), adsorbed |
SUPPORTED |
|
| 139 |
Td(adult) unspecified formulation |
SUPPORTED |
Problem: No forecast series references this code |
| 196 |
Td, adsorbed, preservative free, adult use, Lf unspecified |
SUPPORTED |
Problem: No forecast series references this code |
| 115 |
Tdap |
SUPPORTED |
|
| 190 |
Typhoid conjugate vaccine (TCV) |
SUPPORTED |
Problem: No forecast series references this code |
| 81 |
VEE, inactivated |
SUPPORTED |
Problem: No forecast series references this code |
| 80 |
VEE, live |
SUPPORTED |
|
| 92 |
VEE, unspecified formulation |
SUPPORTED |
Problem: No forecast series references this code |
| 36 |
VZIG |
SUPPORTED |
Problem: No forecast series references this code |
| 117 |
VZIG (IND) |
SUPPORTED |
Problem: No forecast series references this code |
| 183 |
Yellow fever vaccine - alt |
SUPPORTED |
Problem: No forecast series references this code |
| 184 |
Yellow fever, unspecified formulation |
SUPPORTED |
Problem: No forecast series references this code |
| 54 |
adenovirus, type 4 |
SUPPORTED |
Problem: No forecast series references this code |
| 55 |
adenovirus, type 7 |
SUPPORTED |
Problem: No forecast series references this code |
| 82 |
adenovirus, unspecified formulation |
SUPPORTED |
Problem: No forecast series references this code |
| 24 |
anthrax |
SUPPORTED |
Problem: No forecast series references this code |
| 181 |
anthrax immune globulin |
SUPPORTED |
Problem: No forecast series references this code |
| 27 |
botulinum antitoxin |
SUPPORTED |
Problem: No forecast series references this code |
| 26 |
cholera |
SUPPORTED |
Problem: No forecast series references this code |
| 173 |
cholera, BivWC |
SUPPORTED |
Problem: No forecast series references this code |
| 172 |
cholera, WC-rBS |
SUPPORTED |
Problem: No forecast series references this code |
| 174 |
cholera, live attenuated |
SUPPORTED |
Problem: No forecast series references this code |
| 56 |
dengue fever |
SUPPORTED |
Problem: No forecast series references this code |
| 12 |
diphtheria antitoxin |
SUPPORTED |
Problem: No forecast series references this code |
| 57 |
hantavirus |
SUPPORTED |
Problem: No forecast series references this code |
| 60 |
herpes simplex 2 |
SUPPORTED |
Problem: No forecast series references this code |
| 123 |
influenza, H5N1-1203 |
SUPPORTED |
Problem: No forecast series references this code |
| 200 |
influenza, Southern Hemisphere, pediatric, preservative free |
SUPPORTED |
Problem: No forecast series references this code |
| 201 |
influenza, Southern Hemisphere, preservative free |
SUPPORTED |
Problem: No forecast series references this code |
| 202 |
influenza, Southern Hemisphere, quadrivalent, with preservative |
SUPPORTED |
Problem: No forecast series references this code |
| 197 |
influenza, high-dose, quadrivalent |
SUPPORTED |
Problem: No forecast series references this code |
| 166 |
influenza, intradermal, quadrivalent, preservative free |
SUPPORTED |
|
| 149 |
influenza, live, intranasal, quadrivalent |
SUPPORTED |
|
| 185 |
influenza, recombinant, quadrivalent,injectable, preservative
free
|
SUPPORTED |
|
| 168 |
influenza, trivalent, adjuvanted |
SUPPORTED |
|
| 64 |
leishmaniasis |
SUPPORTED |
Problem: No forecast series references this code |
| 65 |
leprosy |
SUPPORTED |
Problem: No forecast series references this code |
| 67 |
malaria |
SUPPORTED |
Problem: No forecast series references this code |
| 05 |
measles |
SUPPORTED |
|
| 68 |
melanoma |
SUPPORTED |
Problem: No forecast series references this code |
| 191 |
meningococcal A polysaccharide (non-US) |
SUPPORTED |
Problem: No forecast series references this code |
| 192 |
meningococcal AC polysaccharide (non-US) |
SUPPORTED |
Problem: No forecast series references this code |
| 163 |
meningococcal B, OMV |
SUPPORTED |
|
| 162 |
meningococcal B, recombinant |
SUPPORTED |
|
| 164 |
meningococcal B, unspecified |
SUPPORTED |
|
| 103 |
meningococcal C conjugate |
SUPPORTED |
Problem: No forecast series references this code |
| 147 |
meningococcal MCV4, unspecified formulation |
SUPPORTED |
|
| 114 |
meningococcal MCV4P |
SUPPORTED |
|
| 32 |
meningococcal MPSV4 |
SUPPORTED |
|
| 203 |
meningococcal polysaccharide (groups A, C, Y, W-135) TT conjugate |
SUPPORTED |
Problem: No forecast series references this code |
| 167 |
meningococcal, unknown serogroups |
SUPPORTED |
Problem: No forecast series references this code |
| 108 |
meningococcal, unspecified formulation |
SUPPORTED |
|
| 07 |
mumps |
SUPPORTED |
|
| 998 |
no vaccine administered |
SUPPORTED |
Problem: No forecast series references this code |
| 69 |
parainfluenza-3 |
SUPPORTED |
Problem: No forecast series references this code |
| 11 |
pertussis |
SUPPORTED |
Problem: No forecast series references this code |
| 23 |
plague |
SUPPORTED |
Problem: No forecast series references this code |
| 100 |
pneumococcal conjugate PCV 7 |
SUPPORTED |
|
| 33 |
pneumococcal polysaccharide PPV23 |
SUPPORTED |
|
| 109 |
pneumococcal, unspecified formulation |
SUPPORTED |
|
| 89 |
polio, unspecified formulation |
SUPPORTED |
|
| 40 |
rabies, intradermal injection |
SUPPORTED |
Problem: No forecast series references this code |
| 18 |
rabies, intramuscular injection |
SUPPORTED |
|
| 90 |
rabies, unspecified formulation |
SUPPORTED |
Problem: No forecast series references this code |
| 72 |
rheumatic fever |
SUPPORTED |
Problem: No forecast series references this code |
| 119 |
rotavirus, monovalent |
SUPPORTED |
|
| 116 |
rotavirus, pentavalent |
SUPPORTED |
|
| 74 |
rotavirus, tetravalent |
SUPPORTED |
|
| 122 |
rotavirus, unspecified formulation |
SUPPORTED |
|
| 06 |
rubella |
SUPPORTED |
|
| 38 |
rubella/mumps |
SUPPORTED |
|
| 180 |
tetanus immune globulin |
SUPPORTED |
Problem: No forecast series references this code |
| 35 |
tetanus toxoid, adsorbed |
SUPPORTED |
Problem: No forecast series references this code |
| 142 |
tetanus toxoid, not adsorbed |
SUPPORTED |
Problem: No forecast series references this code |
| 112 |
tetanus toxoid, unspecified formulation |
SUPPORTED |
Problem: No forecast series references this code |
| 77 |
tick-borne encephalitis |
SUPPORTED |
Problem: No forecast series references this code |
| 78 |
tularemia vaccine |
SUPPORTED |
Problem: No forecast series references this code |
| 101 |
typhoid, ViCPs |
SUPPORTED |
Problem: No forecast series references this code |
| 25 |
typhoid, oral |
SUPPORTED |
Problem: No forecast series references this code |
| 41 |
typhoid, parenteral |
SUPPORTED |
Problem: No forecast series references this code |
| 53 |
typhoid, parenteral, AKD (U.S. military) |
SUPPORTED |
Problem: No forecast series references this code |
| 91 |
typhoid, unspecified formulation |
SUPPORTED |
Problem: No forecast series references this code |
| 131 |
typhus, historical |
SUPPORTED |
Problem: No forecast series references this code |
| 999 |
unknown |
SUPPORTED |
Problem: No forecast series references this code |
| 75 |
vaccinia (smallpox) |
SUPPORTED |
Problem: No forecast series references this code |
| 105 |
vaccinia (smallpox) diluted |
SUPPORTED |
Problem: No forecast series references this code |
| 79 |
vaccinia immune globulin |
SUPPORTED |
Problem: No forecast series references this code |
| 21 |
varicella |
SUPPORTED |
|
| 37 |
yellow fever |
SUPPORTED |
|
| 121 |
zoster |
SUPPORTED |
|
| 187 |
zoster recombinant |
SUPPORTED |
|
| 188 |
zoster, unspecified formulation |
SUPPORTED |
Problem: No forecast series references this code |